Psychopharmacology

Psychopharmacology

  

Assignment Resources

https://mym.cdn.laureate-media.com/2dett4d/Walden/NURS/6630/DT/week_05/1.html

The Assignment: 5 pages

Examine Case Study: A Middle-Aged Caucasian Man With Anxiety. You will be asked to make three decisions concerning the medication to prescribe to this patient. Be sure to consider factors that might impact the patient’s pharmacokinetic and pharmacodynamic processes.

At each decision point, you should evaluate all options before selecting your decision and moving throughout the exercise. Before you make your decision, make sure that you have researched each option and that you evaluate the decision that you will select. Be sure to research each option using the primary literature.

Introduction to the case (1 page)

  • Briefly explain and summarize the case for this Assignment. Be sure      to include the specific patient factors that may impact your decision      making when prescribing medication for this patient.

Decision #1 (1 page)

  • Which decision did you select?
  • Why did you select this decision? Be specific and support your      response with clinically relevant and patient-specific resources,      including the primary literature.
  • Why did you not select the other two options provided in the      exercise? Be specific and support your response with clinically relevant      and patient-specific resources, including the primary literature.
  • What were you hoping to achieve by making this decision? Support      your response with evidence and references to the Learning Resources      (including the primary literature).
  • Explain how ethical considerations may impact your treatment plan      and communication with patients. Be specific and provide examples.

Decision #2 (1 page)

  • Why did you select this decision? Be specific and support your      response with clinically relevant and patient-specific resources,      including the primary literature.
  • Why did you not select the other two options provided in the      exercise? Be specific and support your response with clinically relevant      and patient-specific resources, including the primary literature.
  • What were you hoping to achieve by making this decision? Support      your response with evidence and references to the Learning Resources      (including the primary literature).
  • Explain how ethical considerations may impact your treatment plan      and communication with patients. Be specific and provide examples.

Decision #3 (1 page)

  • Why did you select this decision? Be specific and support your      response with clinically relevant and patient-specific resources,      including the primary literature.
  • Why did you not select the other two options provided in the      exercise? Be specific and support your response with clinically relevant      and patient-specific resources, including the primary literature.
  • What were you hoping to achieve by making this decision? Support      your response with evidence and references to the Learning Resources      (including the primary literature).
  • Explain how ethical considerations may impact your treatment plan      and communication with patients. Be specific and provide examples.

Conclusion (1 page)

  • Summarize your recommendations on the treatment options you      selected for this patient. Be sure to justify your recommendations and      support your response with clinically relevant and patient-specific      resources, including the primary literature.

Note: Support your rationale with a minimum of five academic resources. While you may use the course text to support your rationale, it will not count toward the resource requirement. You should be utilizing the primary and secondary literature.

Learning Resources:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm

Bui, E., Pollack, M. H., Kinrys, G., Delong, H., Vasconcelos e Sá, D., & Simon, N. M. (2016). The pharmacotherapy of anxiety disorders. In T. A. Stern, M. Favo, T. E. Wilens, & J. F. Rosenbaum. (Eds.), Massachusetts General Hospital psychopharmacology and neurotherapeutics (pp. 61–71). Elsevier.

https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/acutestressdisorderptsd.pdf

https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/panicdisorder.pdf

https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/acutestressdisorderptsd-watch.pdf

https://jaacap.org/action/showPdf?pii=S0890-8567%2810%2900082-1

http://bjpo.rcpsych.org/content/2/6/e16

https://search.ebscohost.com/login.aspx?direct=true&db=pst&AN=9999-02824-000&site=eds-live&scope=site&authtype=shib&custid=s6527200

https://go.openathens.net/redirector/waldenu.edu?url=https://jama.jamanetwork.com/journals/jama/fullarticle/2719367

https://search.ebscohost.com/login.aspx?direct=true&db=a9h&AN=74304456&site=ehost-live&scope=site&authtype=shib&custid=s6527200

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>